A mechanism of cyclin D1 action encoded in the patterns of gene expression in human cancer

Lamb J, Ramaswamy S, Ford HL, Contreras B, Martinez RV, Kittrell FS, Zahnow CA, Patterson N, Golub TR, Ewen ME. A mechanism of cyclin D1 action encoded in the patterns of gene expression in human cancer. Cell. 2003;114:323–34.

NOTES

Lamb, JustinRamaswamy, SridharFord, Heide LContreras, BernardoMartinez, Robert VKittrell, Frances SZahnow, Cynthia APatterson, NickGolub, Todd REwen, Mark EengCA88843/CA/NCI NIH HHS/F32-CA79197/CA/NCI NIH HHS/P01-CA80111/CA/NCI NIH HHS/R01-CA61253/CA/NCI NIH HHS/R01-CA65842/CA/NCI NIH HHS/Research Support, Non-U.S. Gov'tResearch Support, U.S. Gov't, P.H.S.Cell. 2003 Aug 8;114(3):323-34. doi: 10.1016/s0092-8674(03)00570-1.

Abstract

Here we describe how patterns of gene expression in human tumors have been deconvoluted to reveal a mechanism of action for the cyclin D1 oncogene. Computational analysis of the expression patterns of thousands of genes across hundreds of tumor specimens suggested that a transcription factor, C/EBPbeta/Nf-Il6, participates in the consequences of cyclin D1 overexpression. Functional analyses confirmed the involvement of C/EBPbeta in the regulation of genes affected by cyclin D1 and established this protein as an indispensable effector of a potentially important facet of cyclin D1 biology. This work demonstrates that tumor gene expression databases can be used to study the function of a human oncogene in situ.
Last updated on 02/17/2021